This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Astellas; Alimera Sciences, Inc.; Ocular Therapeutix, Inc ...
This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
After hours: February 3 at 5:26:14 PM EST Loading Chart for VERA ...
After hours: February 4 at 6:46:43 PM EST Loading Chart for NTLA ...
The AI algorithm demonstrated strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces in nAMD patients. The AI's repeatability in estimating retinal hypo-reflective ...
The company offers year-round educational services on the conditions, using this month in particular to guide patients to needed resources. Prevent Blindness again has declared February as Age-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback